Ildong Pharmaceutical signs ‘Fambir’ license agreement with Novartis
Ildong Pharmaceutical(CEO Woong-Sup Yoon) announced on the 25th that the company secured the Korean license of ‘Famvir(generic name: famciclovir),’ a Novartis’ viral herpes treatment, and has started to take marketing activities since this month.
Famvir is a prescription drug used to treat shing...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
